亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南宏方德醫藥科技有限公司  

恩替卡韋一水合物、釓噴酸、釓噴酸單匍銨、鹽酸特比萘芬、紐甜、吉西他濱、替莫普利、2,3-環戊烯并吡啶、氨基丙醛、硝酸舍他康唑、

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:姚璐佳
  • 電話:0531-55505896
  • 郵件:hfdchem@yahoo.com.cn
  • 傳真:0531-88873618
  • QQ:541766821
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 恩替卡韋
恩替卡韋
單價 1.00 / 公斤對比
銷量 暫無
發貨 山東濟南市付款后3天內
庫存 100公斤起訂1公斤
品牌 山東宏富達
型號 209216-23-9
規格 企標
過期 長期有效
更新 2011-06-30 15:48
 
詳細信息

英文名
 
Entecavir hydrate
別名
 
2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
產品名稱
 
恩替卡韋一水合物; 9-(4-羥基-3-羥甲基-2-亞甲基環戊-1-)鳥嘌呤水合物
分子結構
 
 
分子式
 
C12H15N5O3.H2O
分子量
 
295.30
CAS 登錄號
 
209216-23-9
     
物理化學性質
 
密度
 
1.81
©2025 濟南宏方德醫藥科技有限公司 版權所有   技術支持:化工網   訪問量:9925  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |